- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ibrutinib and Tisagenlecleucel
Total 271449 results
-
Institute of Hematology & Blood Diseases HospitalRecruitingChronic Lymphocytic LeukemiaChina
-
Weill Medical College of Cornell UniversityMayo Clinic; Janssen Scientific Affairs, LLCTerminatedWaldenstrom Macroglobulinemia | Waldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia Refractory | Waldenstrom's Disease | Waldenström; Hypergammaglobulinemia | Waldenstrom's Macroglobulinemia of Lymph Nodes | Waldenstrom's Macroglobulinaemia, Without Mention of RemissionUnited States
-
Michael ChoiPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaUnited States, France, United Kingdom, Belgium, Spain, Israel, Puerto Rico, Poland, Russian Federation
-
Fondazione Italiana Linfomi - ETSJanssen-Cilag S.p.A.Recruiting
-
Oncternal Therapeutics, IncPharmacyclics LLC.WithdrawnImmune System Diseases | Lymphoma | Lymphoma, B-Cell | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedLeukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Italy, New Zealand, Poland, Spain
-
Pharmacyclics LLC.Active, not recruitingFollicular LymphomaUnited Kingdom, Portugal, Taiwan, Spain, Belgium, Netherlands, Israel, United States, Czechia, Italy, France, Hungary, Australia, Poland, Canada, Austria, Russian Federation, Greece, Turkey
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruiting
-
Dana-Farber Cancer InstituteAbbVie; Pharmacyclics LLC.Active, not recruitingWaldenstrom Macroglobulinemia | MYD88 Gene MutationUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
-
Royal Marsden NHS Foundation TrustJanssen, LPUnknownGastrooesophageal CancerUnited Kingdom
-
Janssen Pharmaceutical K.K.Completed
-
Jason Robert GotlibNational Cancer Institute (NCI)TerminatedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
Swiss Group for Clinical Cancer ResearchEuropean Mantle Cell Lymphoma NetworkTerminatedMantle Cell LymphomaItaly, Germany, Switzerland
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Inhye AhnBayerWithdrawnChronic Lymphocytic Leukemia (CLL)
-
PETHEMA FoundationActive, not recruitingChronic Lymphocytic LeukemiaSpain
-
Incyte CorporationRecruitingB-Cell MalignanciesUnited States, Spain, Belgium, Japan, Italy, France, United Kingdom, Israel, Turkey, Norway, Korea, Republic of, Czechia, Sweden, Austria, Poland, Hungary, Denmark
-
NeoImmuneTechRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-cell LymphomaUnited States
-
University of California, San DiegoPharmacyclics LLC.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingChronic Graft Versus Host DiseaseUnited States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom
-
Novartis PharmaceuticalsWithdrawn
-
Pharmacyclics LLC.Ohio State UniversityCompletedB-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's Transformation | Prolymphocyctic LeukemiaUnited States
-
University of WashingtonJanssen PharmaceuticalsActive, not recruitingRecurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterTerminatedRecurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1United States
-
Sumitomo Pharma America, Inc.TerminatedChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | SLLUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingMantle-Cell LymphomaFrance, Canada, Spain, United States, Hungary, Korea, Republic of, Greece, Australia, Netherlands, Belgium, United Kingdom, Czechia, Germany, Poland, Italy, Turkey, Ukraine
-
Boehringer IngelheimCompleted
-
Pharmacyclics LLC.AstraZeneca; Janssen Research & Development, LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States
-
French Innovative Leukemia OrganisationAbbVie; Janssen-Cilag Ltd.Active, not recruitingIntermediate Risk Chronic Lymphocytic Leukemia | Fit Patients | Risk-Adapted and MRD-Driven StrategyFrance
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Paolo GhiaRecruitingChronic Lymphocytic LeukemiaItaly
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Belgium, Canada, China, Czechia, Ireland, Israel, Italy, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Deok-Hwan YangNot yet recruitingPrimary Central Nervous System LymphomaKorea, Republic of
-
CelgeneCompletedLeukemia, Lymphocytic, Chronic, B-CellSpain, United States, Italy, Germany, Austria
-
Michael ChoiPharmacyclics LLC.Withdrawn
-
Juno Therapeutics, a Subsidiary of CelgeneRecruitingLeukemia, Lymphocytic, Chronic, B-Cell | Lymphoma, Small LymphocyticUnited States
-
Andrew RezvaniNational Institutes of Health (NIH); Pharmacyclics LLC.CompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Hematopoietic Cell Transplantation Recipient | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Biphenotypic LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLC; Xynomic Pharmaceuticals, Inc.Active, not recruitingMantle Cell Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Pharmacyclics LLC.CompletedBreast Cancer | Pancreatic Cancer | Non-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedHIV Infection | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular... and other conditionsUnited States
-
Ludwig-Maximilians - University of MunichHoffmann-La Roche; Janssen-Cilag G.m.b.HActive, not recruitingIndolent Non-Hodgkin LymphomaGermany
-
Grupo Argentino de Tratamiento de la Leucemia AgudaNot yet recruitingChronic Lymphocytic Leukemia
-
Bnai Zion Medical CenterTel-Aviv Sourasky Medical CenterRecruiting
-
University of UlmAbbVie; Roche Pharma AG; Janssen-Cilag Ltd.; German CLL Study GroupCompletedLeukemia, Lymphocytic, ChronicGermany
-
Institut Paoli-CalmettesCHU de ReimsUnknownAutoimmune Cytopenia Associated With Chronic Lymphocytic LeukemiaFrance